Prestige Consumer Healthcare Total Long-Term Assets 2010-2024 | PBH

Prestige Consumer Healthcare total long-term assets from 2010 to 2024. Total long-term assets can be defined as the sum of all assets classified as non-current
Prestige Consumer Healthcare Annual Total Long-Term Assets
(Millions of US $)
2024 $2,943
2023 $2,962
2022 $3,377
2021 $3,159
2020 $3,148
2019 $3,140
2018 $3,457
2017 $3,577
2016 $2,700
2015 $2,440
2014 $1,618
2013 $1,576
2012 $1,611
2011 $949
2010 $679
2009 $698
Prestige Consumer Healthcare Quarterly Total Long-Term Assets
(Millions of US $)
2024-06-30 $2,939
2024-03-31 $2,943
2023-12-31 $2,946
2023-09-30 $2,945
2023-06-30 $2,954
2023-03-31 $2,962
2022-12-31 $3,341
2022-09-30 $3,342
2022-06-30 $3,358
2022-03-31 $3,377
2021-12-31 $3,384
2021-09-30 $3,371
2021-06-30 $3,151
2021-03-31 $3,159
2020-12-31 $3,168
2020-09-30 $3,164
2020-06-30 $3,155
2020-03-31 $3,148
2019-12-31 $3,164
2019-09-30 $3,160
2019-06-30 $3,150
2019-03-31 $3,140
2018-12-31 $3,375
2018-09-30 $3,383
2018-06-30 $3,454
2018-03-31 $3,457
2017-12-31 $3,566
2017-09-30 $3,571
2017-06-30 $3,571
2017-03-31 $3,577
2016-12-31 $2,520
2016-09-30 $2,551
2016-06-30 $2,597
2016-03-31 $2,700
2015-12-31 $2,413
2015-09-30 $2,421
2015-06-30 $2,435
2015-03-31 $2,440
2014-12-31 $2,480
2014-09-30 $2,503
2014-06-30 $1,694
2014-03-31 $1,618
2013-12-31 $1,620
2013-09-30 $1,625
2013-06-30 $1,573
2013-03-31 $1,576
2012-12-31 $1,580
2012-09-30 $1,608
2012-06-30 $1,608
2012-03-31 $1,611
2011-12-31 $940
2011-09-30 $943
2011-06-30 $947
2011-03-31 $949
2010-12-31 $874
2010-09-30 $669
2010-06-30 $676
2010-03-31 $679
2009-12-31 $681
2009-09-30 $691
2009-06-30 $695
2009-03-31 $698
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $3.644B $1.125B
Prestige Consumer Healthcare Inc. is a consumer healthcare products company. Its diverse portfolio of brands include Monistat(R) and Summer's Eve(R) women's health products, BC(R) and Goody's(R) pain relievers, Clear Eyes(R) and TheraTears(R) eye care products, DenTek(R) specialty oral care products, Dramamine(R) motion sickness treatments, Fleet(R) enemas and glycerin suppositories, Chloraseptic(R) and Luden's(R) sore throat treatments and drops, Compound W(R) wart treatments, Little Remedies(R) pediatric over-the-counter products, Boudreaux's Butt Paste(R) diaper rash ointments, Nix(R) lice treatment, Debrox(R) earwax remover, Gaviscon(R) antacid in Canada, and Hydralyte(R) rehydration products and the Fess(R) line of nasal and sinus care products in Australia. Prestige Consumer Healthcare Inc., formerly known as Prestige Brands Holdings Inc., is based in Tarrytown, New York.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $199.879B 25.82
Stryker (SYK) United States $137.705B 32.18
Boston Scientific (BSX) United States $121.595B 37.03
Medtronic (MDT) Ireland $113.026B 16.82
EssilorLuxottica (ESLOY) France $104.378B 0.00
Haleon (HLN) United Kingdom $48.118B 35.17
Lonza Group Ag (LZAGY) Switzerland $45.437B 0.00
ResMed (RMD) United States $34.974B 30.79
Koninklijke Philips (PHG) Netherlands $29.016B 22.05
Terumo (TRUMY) Japan $27.876B 39.37
Zimmer Biomet Holdings (ZBH) United States $21.644B 13.63
Baxter (BAX) United States $20.086B 13.62
Insulet (PODD) United States $16.555B 69.65
Smith & Nephew SNATS (SNN) United Kingdom $13.426B 0.00
Bio-Rad Laboratories (BIO) United States $9.489B 31.44
Demant (WILYY) Denmark $9.197B 0.00
BellRing Brands (BRBR) United States $7.672B 32.44
Lantheus Holdings (LNTH) United States $7.508B 18.02
ICU Medical (ICUI) United States $4.304B 41.08
TG Therapeutics (TGTX) United States $3.909B 41.39
Haemonetics (HAE) United States $3.870B 19.14
Perrigo (PRGO) Ireland $3.841B 12.14
GN Store Nord (GNNDY) Denmark $3.758B 22.64
Neogen (NEOG) United States $3.736B 39.18
Envista Holdings (NVST) United States $3.298B 17.60
QuidelOrtho (QDEL) United States $3.108B 19.59
Agios Pharmaceuticals (AGIO) United States $2.591B 0.00
Maravai LifeSciences Holdings (MRVI) United States $2.311B 0.00
Green Thumb Industries (GTBIF) United States $2.171B 36.43
LeMaitre Vascular (LMAT) United States $1.996B 53.20
AdaptHealth (AHCO) United States $1.524B 11.00
InMode (INMD) Israel $1.466B 9.34
Warby Parker (WRBY) United States $1.466B 0.00
AtriCure (ATRC) United States $1.363B 0.00
Owens & Minor (OMI) United States $1.219B 9.41
Verano Holdings (VRNOF) United States $1.114B 0.00
BioLife Solutions (BLFS) United States $1.094B 0.00
Evolus (EOLS) United States $1.023B 0.00
PetIQ (PETQ) United States $0.920B 23.32
Phibro Animal Health (PAHC) United States $0.897B 18.61
National Vision Holdings (EYE) United States $0.864B 27.48
Cresco Labs (CRLBF) United States $0.801B 0.00
Surmodics (SRDX) United States $0.561B 119.09
Quanterix (QTRX) United States $0.543B 0.00
ZimVie (ZIMV) United States $0.454B 42.23
VAREX IMAGING (VREX) United States $0.451B 13.62
Valneva SE (VALN) France $0.422B 0.00
Canopy Growth (CGC) Canada $0.406B 0.00
Jin Medical (ZJYL) China $0.397B 0.00
TerrAscend (TSNDF) Canada $0.333B 0.00
Cerus (CERS) United States $0.330B 0.00
OraSure Technologies (OSUR) United States $0.321B 8.29
Aurora Cannabis (ACB) Canada $0.320B 0.00
Biote (BTMD) United States $0.319B 14.70
Viemed Healthcare (VMD) United States $0.287B 30.79
Sanara MedTech (SMTI) United States $0.272B 0.00
Zynex (ZYXI) United States $0.260B 45.44
Utah Medical Products (UTMD) United States $0.234B 15.52
Ayr Wellness (AYRWF) United States $0.232B 0.00
Omeros (OMER) United States $0.228B 0.00
MacroGenics (MGNX) United States $0.207B 0.00
Organigram Holdings (OGI) Canada $0.196B 0.00
High Tide (HITI) Canada $0.170B 70.33
Capricor Therapeutics (CAPR) United States $0.167B 0.00
FitLife Brands (FTLF) United States $0.153B 20.62
Brainsway (BWAY) Israel $0.140B 168.00
TriSalus Life Sciences (TLSI) United States $0.135B 0.00
Rockwell Medical (RMTI) United States $0.125B 0.00
Quipt Home Medical (QIPT) United States $0.124B 0.00
Veru (VERU) United States $0.113B 0.00
Fonar (FONR) United States $0.110B 11.15
Jushi Holdings (JUSHF) United States $0.103B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.099B 24.20
InterCure (INCR) Israel $0.085B 14.31
Safety Shot (SHOT) United States $0.082B 0.00
Cytosorbents (CTSO) United States $0.077B 0.00
Zevia PBC (ZVIA) United States $0.076B 0.00
Cellectar Biosciences (CLRB) United States $0.075B 0.00
Modular Medical (MODD) United States $0.073B 0.00
MariMed (MRMD) United States $0.065B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.056B 3.63
Exagen (XGN) United States $0.049B 0.00
Allurion Technologies (ALUR) United States $0.041B 0.00
Apyx Medical (APYX) United States $0.036B 0.00
Bright Green (BGXX) United States $0.028B 0.00
ImmuCell (ICCC) United States $0.028B 0.00
Meihua Medical Technologies (MHUA) China $0.026B 0.00
Nephros (NEPH) United States $0.019B 0.00
GlucoTrack (GCTK) United States $0.016B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
GUARDION HEALTH (GHSI) United States $0.013B 0.00
Innovative Eyewear (LUCY) United States $0.013B 0.00
Trinity Biotech (TRIB) Ireland $0.011B 0.00
Agape ATP (ATPC) $0.008B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00
Sharps Technology (STSS) United States $0.007B 0.00
IM Cannabis (IMCC) Canada $0.005B 0.00
Leafly Holdings (LFLY) United States $0.005B 0.00
Senestech (SNES) United States $0.001B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.001B 0.00
Akanda (AKAN) United Kingdom $0.000B 0.00
Smart For Life (SMFL) United States $0.000B 0.00
United-Guardian (UG) United States $0.000B 20.47
SNDL (SNDL) Canada $0.000B 0.00